GE Healthcare

295 articles with GE Healthcare

• GE Healthcare starts to manufacture single-use consumables in China through collaboration with Wego

  11/7/2018

  GE Healthcare partners with Wego to provide locally manufactured single-use consumables for bioprocessing in China

• CHI Franciscan Partners with GE Healthcare to Bring First AI-Powered Hospital Mission Control Center to Washington State

  9/27/2018

  Advanced Analytics Software Platform Will Enhance Patient Safety, Speed Delivery of Care, and Support Quality Outcomes

• Cobra Biologics, GE Healthcare and Centre for Process Innovation Collaborate to Advance Gene Therapy

  9/25/2018

  Innovate UK funded project supports development of scalable, cost effective production of regenerative medicines

• 

  CRISPR Pioneer Jennifer Doudna Opens Lab at Bay Area’s Gladstone Institutes

  9/7/2018

  CRISPR pioneer Jennifer Doudna has set up shop in San Francisco’s Gladstone Institutes. Doudna, a UC Berkley professor credited with the co-discovery of CRISPR-Cas9 genome editing technique, will focus on the development of new ways to implement the gene-editing technique for disease treatment.

• Swedish Government and GE Healthcare Open an Innovation Center for Life Sciences

  8/21/2018

  Swedish biotech BioLamina relies on Testa Center to expand.

• Neuralstem Appoints Jim Scully as Interim Chief Executive Officer

  8/6/2018

  Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of nervous system therapies based on its neural stem cell and small molecule compound technologies, today announced that the Board of Directors has appointed Jim Scully as interim chief executive officer.

• GE Healthcare and Lantheus Announce Start of a Phase 3 Clinical Trial of Flurpiridaz, an Investigational Agent Being Evaluated for the Detection of Coronary Artery Disease

  7/31/2018

  GE Healthcare and Lantheus Holdings, Inc. (NASDAQ: LNTH), have started a second Phase 3 clinical trial of Flurpiridaz.

• 

  GE to Spin Off GE Healthcare as a Standalone Company

  6/27/2018

  GE Healthcare will be spun off from General Electric (GE) within the next 12 to 18 months. It will likely be based in Chicago, where its global headquarters are located.
• 

  A Look at the Top 10 Medical Device Companies in 2018

  6/12/2018

  The medical device market was about $521.2 billion last year and is projected to hit $674.5 billion by 2022. Here’s a look at the top 10 medical device companies in the world this year.

• GE Healthcare FlexFactory Helps XPH Scale Up Industrialization of TCR T-Cell Immunotherapy Drugs

  6/7/2018

  GE Healthcare will provide Xiangxue Pharmaceutical Co., Ltd. (XPH) with a FlexFactory™.

• Tampa General Hospital and GE Healthcare Partner for Next Level Care Coordination

  5/29/2018

  Tampa General Hospital (TGH) and GE Healthcare are partnering to advance care coordination, help enhance patient safety and quality, and improve efficiency with a new care coordination center.

• MaxQ-AI Receives CE Mark Approval for Accipio™Ix Intracranial Hemorrhage Artificial Intelligence Software Platform

  5/22/2018

  MaxQ Artificial Intelligence (MaxQ-AI), a global artificial intelligence (AI) healthcare company, today announced that it has received the CE Mark approval for its revolutionary Accipio software platform.

• Cerner Leads "Big EMR" Market, Epic in "Small EMR" Market, Says Kalorama Information Report

  5/14/2018

  Annual report found market share changed as players dropped out.

• 

  CRISPR Patent Dispute Heats Up Again Today in U.S. Court of Appeals

  4/30/2018

  All that is lacking from the likely drama surrounding patent battles over CRISPR technology in the U.S. Court of Appeals today is Michael Buffer’s cry of “Let’s get ready to rumble.”
• 

  11 Most Innovative Life Science Companies in the World

  2/21/2018

  Here is a look at the life science companies viewed as the most innovative in the world.

• CBMG Accelerates Cell Therapy Manufacturing with GE Healthcare’s New Start-to-Finish Solution

  1/19/2018

  There are more than 900 regenerative medicine trials underway globally, including trials in cell and gene therapy, a 19 percent increase since 2016

• GE, Roche Enter Partnership to Develop Integrated Digital Diagnostics Platform to Improve Oncology and Critical Care Treatment

  1/8/2018

  The partnership will initially focus on products that accelerate and improve individualized treatment options for cancer and critical care patients.

• Check-Cap Announces Advancement in GE Healthcare Manufacturing Collaboration

  12/6/2017

  Check-Cap will supply GE with supporting calibration and final assembly methodology and equipment.

• GE Introduces Healthcare Technology Company to Revolutionize Blood Collection

  11/29/2017

  Drawbridge Health to simplify the collection and transport of blood samples.

• RiboBio and GE Healthcare Enter Into a Strategic Partnership for Oligonucleotide Drug Development and Manufacturing

  11/21/2017

  At the 5th CNAF in Guangzhou, China, Guangzhou RiboBio and GE Healthcare Life Sciences held a strategic partnership signing ceremony.